Anavex Life Sciences Corp (AVXL)
Financing Cash Flow
$46.57M
TTM · Period ending: · USD
AVXL Financing Cash Flow
Latest reported$46.57Mperiod ending
Latest reported$46.57Mperiod ending
AVXL TTM Cash from Financing ($33.94K → $46.57M)
TTM financing cash flow
High-resolution chart · PNG
AVXL financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 46,566,000 | |
| 44,310,000 | |
| 45,049,000 | |
| 9,434,000 | |
| -494,000 | |
| 6,199,000 | |
| 12,624,000 | |
| 11,975,000 | |
| 13,942,326 | |
| 18,395,326 | |
| 29,452,326 | |
| 29,651,326 | |
| 27,597,444 | |
| 25,504,730 | |
| 19,006,415 | |
| 21,287,980 | |
| 23,507,744 | |
| 105,819,107 | |
| 129,802,007 | |
| 153,242,401 | |
| 158,904,838 | |
| 74,783,486 | |
| 43,332,441 | |
| 28,350,434 | |
| 23,936,519 | |
| 28,128,767 | |
| 26,835,361 | |
| 17,782,109 | |
| 15,467,597 | |
| 8,434,194 | |
| 5,788,967 | |
| 8,072,787 | |
| 11,755,285 | |
| 13,911,980 | |
| 16,370,922 | |
| 27,270,674 | |
| 23,754,999 | |
| 19,339,162 | |
| 16,451,313 | |
| 3,132,662 | |
| 10,572,625 | |
| 13,653,609 | |
| 13,653,609 | |
| 12,255,844 | |
| 3,492,840 | |
| 357,984 | |
| 9,803,144 | |
| 9,579,458 | |
| 10,407,395 | |
| 10,494,615 | |
| 1,099,455 | |
| 1,111,285 | |
| 528,448 | |
| 573,350 | |
| 807,100 | |
| 1,569,600 | |
| 1,159,137 | |
| 3,505,887 | |
| 3,390,937 | |
| 3,671,512 | |
| 4,310,001 | |
| 4,297,978 | |
| 5,303,648 | |
| 4,510,573 | |
| 4,618,445 | |
| 4,050,702 | |
| 3,327,950 | |
| 3,140,531 | |
| 3,219,948 | |
| 1,995,766 | |
| 2,019,048 | |
| 2,481,467 | |
| 1,881,052 | |
| 1,448,000 | |
| 1,038,000 | |
| 313,000 | |
| 286,665 | |
| 91,279 | |
| 43,726 | |
| 43,726 | |
| 19,000 | |
| 26,386 | |
| 33,939 | |
| 33,939 |